Q: What is Eligard used for?

Eligard is used to treat advanced prostate cancer .

Q: How does Eligard work?

Hormone Suppression Eligard belongs to a class of medications known as gonadotropin-releasing hormone (GnRH) agonists. It works by affecting the pituitary gland, which is responsible for signaling the body to produce sex hormones. When treatment first begins, the medication causes a temporary increase in the production of certain hormones. However, after continuous use, the pituitary gland stops sending signals to the testicles to produce testosterone. This results in testosterone levels falling to very low levels, similar to the levels seen after surgical removal of the testicles. Impact on Prostate Cancer Most prostate cancer cells require testosterone to grow and spread. By depriving these cells of the hormone they need, Eligard can: Slow the growth of the tumor. Shrink the size of the cancer. Help relieve symptoms associated with advanced prostate cancer. Because Eligard is designed as a long-acting injection, it releases the medication slowly over several months to maintain these low hormone levels consistently.

Q: What are the active ingredients in Eligard?

The active ingredient in Eligard is leuprolide .

Q: What are the side effects of Eligard?

Common side effects of Eligard may include: hot flashes injection site reactions fatigue and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Eligard?

Eligard belongs to the GnRH agonist drug class.

Q: What is the dosage of Eligard and how do I take it?

Administration Eligard is given as a subcutaneous injection, which means it is injected into the fatty tissue just beneath the skin. A healthcare professional will prepare and administer the medication in a clinical setting, such as a doctor's office or clinic. Frequency The timing of your injections depends on the specific formulation your doctor prescribes. Common schedules include: Once every month Once every three months Once every four months Once every six months Your healthcare provider will determine the most appropriate schedule for your treatment. It is important to keep all scheduled appointments to ensure the medication remains effective. Injection Sites The injection is typically given in the abdomen, upper buttocks, or other areas where there is enough tissue under the skin. Your healthcare provider will likely rotate the injection site with each dose to reduce the risk of skin irritation. Missed Doses If you miss an appointment for your injection, contact your healthcare provider immediately to reschedule. Maintaining a consistent schedule is necessary for the medication to work properly.

Q: Is Eligard safe during pregnancy and breastfeeding?

Pregnancy Eligard is contraindicated for use during pregnancy. Research and animal studies indicate that leuprolide, the active ingredient, can cause fetal harm or pregnancy loss when administered to a pregnant person. If pregnancy is suspected or confirmed during treatment, it is important to contact a healthcare provider immediately to discuss the potential risks to the fetus. Contraception Because Eligard can cause birth defects, healthcare providers usually recommend using effective non-hormonal birth control methods during treatment. Since this medication affects hormone levels, hormonal contraceptives may not be appropriate or effective. Breastfeeding It is currently unknown if leuprolide passes into human breast milk or what effects it may have on a nursing infant. Due to the potential for serious side effects in a breastfed child, individuals are encouraged to discuss the risks and benefits of breastfeeding with their doctor. A decision may be needed to either stop breastfeeding or stop the medication, depending on the clinical necessity of the treatment.

Q: What is the FDA approval status of Eligard?

FDA Approval and Indications Eligard is approved by the U.S. Food and Drug Administration (FDA) for the palliative treatment of advanced prostate cancer. In this context, palliative treatment is intended to manage symptoms and improve quality of life in cases where the cancer has progressed to an advanced stage. Safety Communications The FDA has issued safety communications regarding the class of medications known as gonadotropin-releasing hormone (GnRH) agonists, which includes Eligard. These communications were based on a review of several studies that suggested a potential increased risk of certain health conditions in men receiving these treatments, including: Diabetes Heart attack Sudden cardiac death Stroke As a result of these findings, the FDA requires the inclusion of information about these risks in the prescribing information for all GnRH agonist products. Healthcare providers are encouraged to monitor patients for the development of diabetes and cardiovascular disease while they are using this medication. Monitoring and Warnings While Eligard does not currently require a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA-approved labeling includes warnings about the "tumor flare" phenomenon. This occurs when testosterone levels briefly rise at the start of treatment, which may cause a temporary worsening of symptoms. The labeling also emphasizes the need for periodic monitoring of serum testosterone and prostate-specific antigen (PSA) levels to ensure the medication is working effectively.

Question 1

What is Eligard?

Accepted Answer

Eligard belongs to a class of medications known as gonadotropin-releasing hormone (GnRH) agonists. It functions by overstimulating the body's natural production of certain hormones, which eventually causes the pituitary gland to stop producing them.

This process leads to a significant decrease in testosterone levels. By lowering these hormone levels, the medication helps slow or stop the growth of cells that rely on testosterone to function.

Question 2

What is Eligard used for?

Accepted Answer

Eligard is used to treat advanced prostate cancer.

Question 3

How does Eligard work?

Accepted Answer

Hormone Suppression

Eligard belongs to a class of medications known as gonadotropin-releasing hormone (GnRH) agonists. It works by affecting the pituitary gland, which is responsible for signaling the body to produce sex hormones.

When treatment first begins, the medication causes a temporary increase in the production of certain hormones. However, after continuous use, the pituitary gland stops sending signals to the testicles to produce testosterone. This results in testosterone levels falling to very low levels, similar to the levels seen after surgical removal of the testicles.

Impact on Prostate Cancer

Most prostate cancer cells require testosterone to grow and spread. By depriving these cells of the hormone they need, Eligard can:

Slow the growth of the tumor.
Shrink the size of the cancer.
Help relieve symptoms associated with advanced prostate cancer.

Because Eligard is designed as a long-acting injection, it releases the medication slowly over several months to maintain these low hormone levels consistently.

Question 4

What are the active ingredients in Eligard?

Accepted Answer

The active ingredient in Eligard is leuprolide.

Question 5

What are the side effects of Eligard?

Accepted Answer

Common side effects of Eligard may include:

hot flashes
injection site reactions
fatigue
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Eligard?

Accepted Answer

Eligard belongs to the GnRH agonist drug class.

Question 7

What is the dosage of Eligard and how do I take it?

Accepted Answer

Administration

Eligard is given as a subcutaneous injection, which means it is injected into the fatty tissue just beneath the skin. A healthcare professional will prepare and administer the medication in a clinical setting, such as a doctor's office or clinic.

Frequency

The timing of your injections depends on the specific formulation your doctor prescribes. Common schedules include:

Once every month
Once every three months
Once every four months
Once every six months

Your healthcare provider will determine the most appropriate schedule for your treatment. It is important to keep all scheduled appointments to ensure the medication remains effective.

Injection Sites

The injection is typically given in the abdomen, upper buttocks, or other areas where there is enough tissue under the skin. Your healthcare provider will likely rotate the injection site with each dose to reduce the risk of skin irritation.

Missed Doses

If you miss an appointment for your injection, contact your healthcare provider immediately to reschedule. Maintaining a consistent schedule is necessary for the medication to work properly.

Question 8

Is Eligard safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Eligard is contraindicated for use during pregnancy. Research and animal studies indicate that leuprolide, the active ingredient, can cause fetal harm or pregnancy loss when administered to a pregnant person. If pregnancy is suspected or confirmed during treatment, it is important to contact a healthcare provider immediately to discuss the potential risks to the fetus.

Contraception

Because Eligard can cause birth defects, healthcare providers usually recommend using effective non-hormonal birth control methods during treatment. Since this medication affects hormone levels, hormonal contraceptives may not be appropriate or effective.

Breastfeeding

It is currently unknown if leuprolide passes into human breast milk or what effects it may have on a nursing infant. Due to the potential for serious side effects in a breastfed child, individuals are encouraged to discuss the risks and benefits of breastfeeding with their doctor. A decision may be needed to either stop breastfeeding or stop the medication, depending on the clinical necessity of the treatment.

Question 9

What forms and strengths does Eligard come in?

Accepted Answer

Eligard is available as a subcutaneous injection. It is supplied in a specialized kit designed for mixing and administration by a healthcare provider.

Kit Components

Pre-filled Syringes: The kit contains syringes that hold the active drug and a liquid delivery system.
Injectable Suspension: The contents of the syringes are mixed together immediately before administration to create a suspension for injection.

The medication is injected into the fatty tissue just beneath the skin, where it is slowly released into the body.

Question 10

What is the FDA approval status of Eligard?

Accepted Answer

FDA Approval and Indications

Eligard is approved by the U.S. Food and Drug Administration (FDA) for the palliative treatment of advanced prostate cancer. In this context, palliative treatment is intended to manage symptoms and improve quality of life in cases where the cancer has progressed to an advanced stage.

Safety Communications

The FDA has issued safety communications regarding the class of medications known as gonadotropin-releasing hormone (GnRH) agonists, which includes Eligard. These communications were based on a review of several studies that suggested a potential increased risk of certain health conditions in men receiving these treatments, including:

Diabetes
Heart attack
Sudden cardiac death
Stroke

As a result of these findings, the FDA requires the inclusion of information about these risks in the prescribing information for all GnRH agonist products. Healthcare providers are encouraged to monitor patients for the development of diabetes and cardiovascular disease while they are using this medication.

Monitoring and Warnings

While Eligard does not currently require a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA-approved labeling includes warnings about the "tumor flare" phenomenon. This occurs when testosterone levels briefly rise at the start of treatment, which may cause a temporary worsening of symptoms. The labeling also emphasizes the need for periodic monitoring of serum testosterone and prostate-specific antigen (PSA) levels to ensure the medication is working effectively.

Question 11

What should I know about Eligard and cost?

Accepted Answer

Insurance and Coverage

Eligard is a prescription medication administered by a healthcare professional, which means it is often covered under the medical benefit portion of insurance plans rather than the pharmacy benefit. For patients with Medicare, it is typically covered under Medicare Part B. The actual out-of-pocket cost will depend on the specific terms of the insurance policy, including deductibles and coinsurance requirements.

Administration Costs

Because Eligard requires specific preparation and must be injected by a medical professional, the total cost usually includes more than just the medication itself. Patients may encounter charges for:

The office visit or clinic fee.
The professional service fee for the injection procedure.
The medication itself, which varies in price based on whether a one-month, three-month, four-month, or six-month dose is used.

Financial Support Options

Financial assistance may be available for eligible patients to help manage the costs of treatment. These options often include:

Copay Savings Programs: Programs designed to reduce the out-of-pocket costs for patients with commercial insurance.
Patient Assistance Programs: Programs that provide the medication at low or no cost to individuals who meet specific income requirements and lack adequate insurance coverage.

Patients are encouraged to speak with their healthcare provider's billing office or their insurance company to understand the expected costs before starting treatment.

Eligard

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Eligard

Hospitals.net Disclosure